Stock listing

OTC:NKGN NKGen Biotech Inc. Stock

Follow NKGen Biotech Inc. into a list and get an email when it puts out news.

Share price · OTC:NKGN

$0.011 USD 0.000 (0.0%)

Close on Oct 29, 2026

Past year -45.0% · daily closes, Oct 29, 2025 – Oct 29, 2026, adjusted for splits
Day range
$0.011 – $0.011 USDOct 29, 2026
Volume
1,500 sharesOct 29, 2026
Market cap
$1.44M USDAt the close on Oct 29, 2026 · price × 130.6M shares outstanding
52-week range
$0.0010 – $0.200 USDLowest and highest trades, Oct 30, 2025 – Oct 29, 2026
Traded on an average day
$41 USDMedian day 0 shares · 31 days with no trades · last 3 months, Jul 29, 2026 – Oct 29, 2026
NKGen Biotech Inc. logo

Daily closes

Last 3 months, Jul 29, 2026 – Oct 29, 2026 · OTC:NKGN · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$0.0110.0000.0%$0.011$0.011$0.0111,500
$0.011+0.000+4.8%$0.011$0.011$0.011330
$0.011+0.001+5.0%$0.011$0.011$0.0111,567
$0.010+0.007+233.3%$0.010$0.010$0.010500
$0.0030-0.008-72.7%$0.0030$0.0030$0.003014,500
$0.0110.0000.0%$0.011$0.011$0.0110
$0.0110.0000.0%$0.011$0.011$0.011400
$0.0110.0000.0%$0.011$0.011$0.0110
$0.0110.0000.0%$0.011$0.011$0.0118,000
$0.0110.0000.0%$0.011$0.011$0.0110
$0.0110.0000.0%$0.011$0.011$0.0110
$0.0110.0000.0%$0.011$0.011$0.0110
$0.0110.0000.0%$0.011$0.011$0.0110
$0.0110.0000.0%$0.011$0.011$0.0115,200
$0.0110.0000.0%$0.011$0.011$0.0110
$0.0110.0000.0%$0.011$0.011$0.0110
$0.0110.0000.0%$0.011$0.011$0.011200
$0.011-0.001-8.3%$0.011$0.011$0.0117,000
$0.0120.0000.0%$0.012$0.012$0.0120
$0.0120.0000.0%$0.012$0.012$0.01210,000
$0.0120.0000.0%$0.012$0.012$0.012200
$0.0120.0000.0%$0.012$0.012$0.0120
$0.0120.0000.0%$0.012$0.012$0.0120
$0.0120.0000.0%$0.012$0.012$0.0122,200
$0.0120.0000.0%$0.012$0.012$0.0120
$0.012+0.010+500.0%$0.011$0.012$0.01048,200
$0.00200.0000.0%$0.0020$0.0020$0.00200
$0.00200.0000.0%$0.0020$0.0020$0.00200
$0.00200.0000.0%$0.0020$0.0020$0.0020100
$0.00200.0000.0%$0.0020$0.0020$0.00200
$0.00200.0000.0%$0.0020$0.0020$0.002010,000
$0.00200.0000.0%$0.0020$0.0020$0.0020300
$0.00200.0000.0%$0.0020$0.0020$0.00200
$0.00200.0000.0%$0.0020$0.0020$0.00200
$0.00200.0000.0%$0.0020$0.0020$0.0020400
$0.00200.0000.0%$0.0020$0.0020$0.00200
$0.00200.0000.0%$0.0020$0.0020$0.00201,900
$0.00200.0000.0%$0.0020$0.0020$0.00202,500
$0.00200.0000.0%$0.0020$0.0020$0.00200
$0.00200.0000.0%$0.0020$0.0020$0.00203,800
$0.00200.000-4.8%$0.0020$0.0020$0.00201,500
$0.0021-0.003-58.8%$0.0021$0.0021$0.00212,001
$0.0051+0.000+2.0%$0.0051$0.0051$0.0051200
$0.00500.0000.0%$0.0050$0.0050$0.00500
$0.00500.0000.0%$0.0050$0.0050$0.00500
$0.00500.0000.0%$0.0050$0.0050$0.00502,000
$0.00500.0000.0%$0.0050$0.0050$0.00500
$0.00500.0000.0%$0.0050$0.0050$0.0050300
$0.00500.0000.0%$0.0050$0.0050$0.00500
$0.00500.0000.0%$0.0050$0.0050$0.00500
$0.00500.0000.0%$0.0050$0.0050$0.00500
$0.00500.0000.0%$0.0050$0.0050$0.0050500
$0.00500.0000.0%$0.0050$0.0050$0.00502,100
$0.00500.0000.0%$0.0050$0.0050$0.00500
$0.00500.0000.0%$0.0050$0.0050$0.00500
$0.00500.0000.0%$0.0050$0.0050$0.00500
$0.0050-0.005-50.0%$0.0050$0.0050$0.00503,100
$0.0100.0000.0%$0.010$0.010$0.0100
$0.0100.0000.0%$0.010$0.010$0.0100
$0.010-0.050-83.3%$0.060$0.060$0.0010140,100
$0.0600.0000.0%$0.060$0.060$0.0600
Ticker
OTC:NKGN
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
OTC
Currency
USD

What changed lately

Latest news

NKGen Biotech to Present on Troculeucel for Neurodegenerative Diseases at 4th Great Bay Cell and Gene Therapy Forum

Sep 15, 2026

Closed $0.0020 (0.0%) on Sep 15, 2026

NKGen Biotech to Present on Potential of Troculeucel in Neurodegenerative Diseases at Biologics Manufacturing Korea 2026

Sep 10, 2026

Closed $0.0020 (0.0%) on Sep 10, 2026

NKGen Biotech to Present Troculeucel Mechanism Data in Alzheimer’s and Frontotemporal Dementia at the Neuroimmunology Drug Development Summit

Apr 9, 2026

Closed $0.06 (0.0%) on Apr 9, 2026

NKGen Biotech Reports Combined Phase 1 Troculeucel Data Demonstrating Dose-Responsive Cognitive Improvements and Biomarker Correlations in Alzheimer’s Disease at AD/PD 2026™

Mar 23, 2026

Closed $0.16 (+6.7%) on Mar 23, 2026

NKGen Biotech Names Leading Dementia Expert Bruce L. Miller, M.D. to Scientific Advisory Board

Jan 22, 2026

Closed $0.06 (0.0%) on Jan 22, 2026

NKGen Biotech, Inc. Issues Statement on Recent Board Appointments at Majority-Owned Korean Affiliate NKGen Korea Co., Ltd.

Dec 3, 2025

Closed $0.037 (+2.8%) on Dec 3, 2025

NKGen Biotech Provides Clarification on Quotation Display and Trading Status on the OTC Expert Market

Oct 9, 2025

NKGen Biotech to Present on the Use of Troculeucel for Neurodegenerative Diseases at the XXVII World Congress of Neurology

Oct 6, 2025

NKGen Biotech to Present on the Use of Troculeucel for Neurodegenerative Diseases at the 3rd China Great Bay Cell and Gene Therapy Forum

Sep 18, 2025

NKGen Biotech, Inc. Announces Completion of NKMax Co., Ltd. Acquisition; Gains Full Control of Global Manufacturing and Intellectual Property Assets

Sep 9, 2025

All NKGen Biotech Inc. news

Decks

NKGen Biotech Inc. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
6 in the last 12 months · 29 in all · newest Sep 15, 2026 · oldest 2025
Decks
14 decks · latest March 2026

Log in to ask 6ix AI your own questions about NKGen Biotech Inc.